Andrew Arno - 24 Jun 2021 Form 4 Insider Report for OncoCyte Corp (OCX)

Role
Director
Signature
/s/ Andrew Arno
Issuer symbol
OCX
Transactions as of
24 Jun 2021
Transactions value $
$0
Form type
4
Filing time
28 Jun 2021, 20:30:13 UTC
Next filing
20 Jan 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OCX Option to Purchase Common Stock Award $0 +45,000 $0 45,000 24 Jun 2021 Common Stock 45,000 $5.46 Direct F1
transaction OCX Restricted Stock Units Award $0 +10,000 $0 10,000 24 Jun 2021 Common Stock 10,000 $0 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Options shall vest one year from the date of grant, subject to the director's continued service as a director of the Company from the date of grant until the vesting date or, if earlier, until the next annual meeting of shareholders.
F2 The Restricted Stock Units shall vest one year from the date of grant, subject to the director's continued service as a director of the Company from the date of grant until the vesting date or, if earlier, until the next annual meeting of shareholders.